Matthew Morgan
Direttore/Membro del Consiglio presso TOTL BRAI
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Evian Gordon | M | - | 24 anni | |
Camillo Martino | M | 61 | 6 anni | |
Steven Godinho | M | - |
Xbio Systems, Inc.
Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | 18 anni |
Phillip Ashley Campbell | M | - | 5 anni | |
Brian O'Sullivan | M | - | 5 anni | |
Ken Murley | M | - |
Xbio Systems, Inc.
Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | - |
Grant Yeatman | M | - | 4 anni | |
Phillip Hains | M | 64 | 8 anni | |
Matthew Mund | M | - | 7 anni | |
Simon Poidevin | M | 65 | 2 anni | |
Alan B. Forsythe | M | - |
Xbio Systems, Inc.
Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | - |
Joel Voss | M | - | 8 anni | |
Donna Palmer | M | - | 2 anni | |
Simon Peeke | M | - | 5 anni | |
Nathan Jong | M | - | 5 anni | |
David Torrible | M | - | 5 anni | |
Alasdair Jeffrey | M | - | - | |
Peter Liss | M | - | 6 anni | |
Michael Bernard Ohanessian | M | 60 | 10 anni | |
Ivan M. Ruzic | M | - |
Xbio Systems, Inc.
Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | - |
Gene Clouse | M | - |
Xbio Systems, Inc.
Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | - |
Joe Godcharles | M | - |
Xbio Systems, Inc.
Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | - |
Rhys Davies | M | - |
Xbio Systems, Inc.
Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | - |
Manny Sayanos | M | - |
Xbio Systems, Inc.
Xbio Systems, Inc. Information Technology ServicesTechnology Services Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle. | - |
Mark Andrew Read | M | 63 | 1 anni | |
Callum Philips | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Dan Segal | M | 63 | 16 anni | |
Dan Drewe | M | - | 3 anni | |
Vincent Parrott | M | - | - | |
Alex Baker | M | - | 8 anni | |
Stuart Korchinski | M | 60 | 5 anni | |
Tim Pritchard | M | - | 4 anni | |
Angus Craig | M | 53 | 19 anni | |
Joseph M. Baini | M | 58 | 6 anni | |
Linton Burns | M | - | 4 anni | |
Andrew Ritter | M | - | 2 anni | |
Christopher Gerard O'Neill | M | - | 2 anni | |
Timothy Brown | M | 62 | 3 anni | |
Louis Gagnon | M | - | 4 anni | |
Jason Chaffey | M | - | 8 anni | |
Charles Rottier | M | - | 3 anni | |
Nigel Finch | M | 55 |
3D Medical Ltd.
3D Medical Ltd. Medical SpecialtiesHealth Technology 3D Medical Ltd. engages in the manufacturing and distributing of safety syringe products. The company is involved in the research and development of medical syringe technology and mineral exploration. Its products include Medical 3D Printing, Enterprise Imaging Platform, Holographic Workstation, Theatre Motion Control and Big Data. The company was founded by John Riemelmoser on January 20, 1977 and is headquartered in Port Melbourne, Australia. | - |
Ronald Finkel | M | - | 2 anni | |
Helen Pennisi | F | - | 2 anni | |
Richard Robinson | M | - | 4 anni | |
Robert John Waring | M | - | 17 anni | |
Douglas John Rathbone | M | 77 | 7 anni | |
Allan Brackin | M | - | 2 anni | |
Gregory Baynton | M | 55 | 2 anni | |
Stephen Bizzell | M | 56 | 6 anni | |
David James Stuart Hetzel | M | - | 7 anni | |
Brad Sherrard | M | 57 | 2 anni | |
Laurie Paxton | F | - | 3 anni | |
Jason Lowry | M | - | 1 anni | |
Michael Casey | M | - | 3 anni | |
Marc Sabourin | M | - | 2 anni | |
Melissa Frieswick | F | - | 2 anni | |
Ajay Arora | M | - | 2 anni | |
Sarah Zeljko | F | - | 3 anni | |
Stephen Koslow | M | - | 3 anni | |
Terence Gray | M | - | 2 anni | |
Matt Resteghini | M | - | 4 anni | |
Craig Sheather | M | - | - | |
Harvey Bui | M | - | 1 anni | |
David Garrison | M | 55 | 4 anni | |
Frank Pertile | M | 52 |
3D Medical Ltd.
3D Medical Ltd. Medical SpecialtiesHealth Technology 3D Medical Ltd. engages in the manufacturing and distributing of safety syringe products. The company is involved in the research and development of medical syringe technology and mineral exploration. Its products include Medical 3D Printing, Enterprise Imaging Platform, Holographic Workstation, Theatre Motion Control and Big Data. The company was founded by John Riemelmoser on January 20, 1977 and is headquartered in Port Melbourne, Australia. | 1 anni |
Ian Lindsay Campbell | M | - | 1 anni | |
Ralph Schmitt | M | 63 | 5 anni | |
Dave Daglio | M | - | 2 anni | |
George L. Lauro | M | 65 | 4 anni | |
Ron Dewhurst | M | 71 | - | |
Simon Jenkins | M | - |
3D Medical Ltd.
3D Medical Ltd. Medical SpecialtiesHealth Technology 3D Medical Ltd. engages in the manufacturing and distributing of safety syringe products. The company is involved in the research and development of medical syringe technology and mineral exploration. Its products include Medical 3D Printing, Enterprise Imaging Platform, Holographic Workstation, Theatre Motion Control and Big Data. The company was founded by John Riemelmoser on January 20, 1977 and is headquartered in Port Melbourne, Australia. | 1 anni |
Peter James Christie | M | 62 |
3D Medical Ltd.
3D Medical Ltd. Medical SpecialtiesHealth Technology 3D Medical Ltd. engages in the manufacturing and distributing of safety syringe products. The company is involved in the research and development of medical syringe technology and mineral exploration. Its products include Medical 3D Printing, Enterprise Imaging Platform, Holographic Workstation, Theatre Motion Control and Big Data. The company was founded by John Riemelmoser on January 20, 1977 and is headquartered in Port Melbourne, Australia. | 5 anni |
Ian Hobson | M | 59 | - | |
Nestor Hinzack | M | - | 16 anni | |
Brian O'Loughlin | M | - | 4 anni | |
Arthur Toga | M | - | 16 anni | |
William Baum | M | 79 | 3 anni | |
Deborah Ho | F | - |
3D Medical Ltd.
3D Medical Ltd. Medical SpecialtiesHealth Technology 3D Medical Ltd. engages in the manufacturing and distributing of safety syringe products. The company is involved in the research and development of medical syringe technology and mineral exploration. Its products include Medical 3D Printing, Enterprise Imaging Platform, Holographic Workstation, Theatre Motion Control and Big Data. The company was founded by John Riemelmoser on January 20, 1977 and is headquartered in Port Melbourne, Australia. | 3 anni |
Garry Crole | M | 59 | 4 anni | |
Emil Vasilev | M | - | 4 anni | |
Melissa Morrison | F | - | 1 anni | |
Les Edye | M | - | 5 anni | |
Matthew Cooper | M | - | 1 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Australia | 84 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Matthew Morgan
- Contatti personali